1. Larsen PL, Tos M (1997) Origin and structure of nasal polyps. In: Mygind N, Lildholdt T (eds) Nasal Polyposis: an inflammatory disease and its treatment. Munksgaard, Copenhagen, pp 17–30
2. Rugina M, Serrano E, Klossek JM, Crampette L, Stoll D, Begear JP et al (2002) Epidemiological and clinical aspects of nasal polyposis in France: the ORLI group experience. Rhinology 40:75–79
3. Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB, Wallaert B (1999) Quality of life in nasal polyposis. J Allergy Clin Immunol 104(1):79–84
4. Alobid I, Benítez P, Bernal-Sprekelsen M, Guilemany JM, Picado C, Mullol J (2005) The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res 14(3):789–793
5. Riccioni G, Bucciarelli T, Di Ilio C, Corradi F, Della Vecchia R, Staniscia T, Mattei P, D’Orazio N (2006) Is nasal polyposis a determinant of bronchial hyperresponsiveness and altered quality of life in asthmatic subjects? A case–control study. Ann Clin Lab Sci 36:170–173